AbbVie Inc.
NYSE:ABBV
198.55 (USD) • At close August 5, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 56,334 | 54,318 | 58,054 | 56,197 | 45,804 | 33,266 | 32,753 | 28,216 | 25,638 | 22,859 | 19,960 | 18,790 | 18,380 | 17,443.951 | 15,638 | 14,214.196 |
| Cost of Revenue
| 16,904 | 20,415 | 17,414 | 17,446 | 15,387 | 7,439 | 7,718 | 7,040 | 5,833 | 4,500 | 4,426 | 4,581 | 4,508 | 4,639.393 | 4,293 | 4,056.39 |
| Gross Profit
| 39,430 | 33,903 | 40,640 | 38,751 | 30,417 | 25,827 | 25,035 | 21,176 | 19,805 | 18,359 | 15,534 | 14,209 | 13,872 | 12,804.558 | 11,345 | 10,157.806 |
| Gross Profit Ratio
| 0.7 | 0.624 | 0.7 | 0.69 | 0.664 | 0.776 | 0.764 | 0.75 | 0.772 | 0.803 | 0.778 | 0.756 | 0.755 | 0.734 | 0.725 | 0.715 |
| Reseach & Development Expenses
| 12,791 | 7,675 | 6,510 | 8,046 | 7,755 | 6,792 | 10,753 | 4,982 | 4,366 | 4,285 | 3,297 | 2,855 | 2,778 | 2,617.506 | 2,495 | 1,707.44 |
| General & Administrative Expenses
| 11,089 | 0 | 13,260 | 10,249 | 0 | 5,842 | 6,253 | 5,402 | 5,073 | 4,959 | 5,359 | 4,726 | 4,989 | 5,893.82 | 3,820 | 3,348.572 |
| Selling & Marketing Expenses
| 2,100 | 0 | 2,000 | 2,100 | 0 | 0 | 0 | 846 | 764 | 704 | 665 | 626 | 0 | 0 | 0 | 0 |
| SG&A
| 13,189 | 12,872 | 15,260 | 12,349 | 11,299 | 6,942 | 7,399 | 6,295 | 5,837 | 5,663 | 6,024 | 5,352 | 4,989 | 5,893.82 | 3,820 | 3,348.572 |
| Other Expenses
| 4,313 | 599 | 753 | 432 | 0 | -890 | 500 | 0 | -232 | -13 | 27 | 1 | 9 | 0 | 61 | 0 |
| Operating Expenses
| 30,293 | 21,146 | 22,523 | 20,827 | 19,054 | 12,844 | 18,652 | 11,629 | 10,466 | 10,822 | 11,771 | 8,207 | 7,767 | 8,511.326 | 6,315 | 5,056.012 |
| Operating Income
| 9,137 | 12,757 | 18,117 | 17,924 | 11,363 | 12,983 | 6,383 | 9,545 | 9,340 | 7,537 | 3,411 | 5,664 | 5,817 | 3,620 | 4,717 | 4,931.794 |
| Operating Income Ratio
| 0.162 | 0.235 | 0.312 | 0.319 | 0.248 | 0.39 | 0.195 | 0.338 | 0.364 | 0.33 | 0.171 | 0.301 | 0.316 | 0.208 | 0.302 | 0.347 |
| Total Other Income Expenses Net
| -5,421 | -6,507 | -4,640 | -4,935 | -7,965 | -4,557 | -1,186 | -1,818 | -1,456 | -892 | -1,042 | -332 | -92 | 48 | 119 | 1,018.523 |
| Income Before Tax
| 3,716 | 6,250 | 13,477 | 12,989 | 3,398 | 8,426 | 5,197 | 7,727 | 7,884 | 6,645 | 2,369 | 5,332 | 5,725 | 3,668.527 | 4,836 | 5,950.317 |
| Income Before Tax Ratio
| 0.066 | 0.115 | 0.232 | 0.231 | 0.074 | 0.253 | 0.159 | 0.274 | 0.308 | 0.291 | 0.119 | 0.284 | 0.311 | 0.21 | 0.309 | 0.419 |
| Income Tax Expense
| -570 | 1,377 | 1,632 | 1,440 | -1,224 | 544 | 490 | 2,418 | 1,931 | 1,501 | 595 | 1,204 | 450 | 235.399 | 658 | 1,313.802 |
| Net Income
| 4,278 | 4,863 | 11,836 | 11,542 | 4,616 | 7,882 | 5,687 | 5,309 | 5,953 | 5,144 | 1,774 | 4,128 | 5,275 | 3,433.128 | 4,178 | 4,636.515 |
| Net Income Ratio
| 0.076 | 0.09 | 0.204 | 0.205 | 0.101 | 0.237 | 0.174 | 0.188 | 0.232 | 0.225 | 0.089 | 0.22 | 0.287 | 0.197 | 0.267 | 0.326 |
| EPS
| 2.4 | 2.73 | 6.65 | 6.48 | 2.73 | 5.3 | 3.69 | 3.31 | 3.65 | 3.15 | 1.11 | 2.58 | 3.35 | 2.12 | 2.59 | 2.87 |
| EPS Diluted
| 2.39 | 2.72 | 6.63 | 6.45 | 2.72 | 5.28 | 3.68 | 3.3 | 3.63 | 3.13 | 1.1 | 2.56 | 3.35 | 2.11 | 2.57 | 2.85 |
| EBITDA
| 14,910 | 17,172 | 24,174 | 23,933 | 12,323 | 12,227 | 8,310 | 10,378 | 10,120 | 8,200 | 3,584 | 6,528 | 6,979 | 4,940 | 6,020 | 5,799.286 |
| EBITDA Ratio
| 0.265 | 0.316 | 0.416 | 0.426 | 0.269 | 0.368 | 0.254 | 0.368 | 0.395 | 0.359 | 0.18 | 0.347 | 0.38 | 0.283 | 0.385 | 0.408 |